Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Santaris Nabs Isis, Amgen Vets Luke Timmerman 10/28/09 San Diego
Yale startup 3PrimiR Raises $2.1M Ryan McBride 09/16/09 Boston
MicroRNA Drug Developer Santaris Establishes Toehold in San Diego With Isis Veteran Luke Timmerman 09/16/09 San Diego
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News Eric Hal Schwartz 07/30/09 San Diego
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’ Luke Timmerman 07/28/09 San Diego
Archemix Signs MicroRNA Deal Luke Timmerman 07/23/09 Boston
Regulus Hits GSK Milestone Luke Timmerman 05/14/09 San Diego
Leroy Hood, ISB Scientists Spot Genes For “Mad Cow” Disease; May Lead to Diagnostic Test Luke Timmerman 03/24/09 Seattle
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines Luke Timmerman 02/18/09 Boston
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis Luke Timmerman 01/21/09 San Diego
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure Luke Timmerman 11/30/08 San Diego
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments Luke Timmerman 10/24/08 San Diego
Dendreon Proceeds With Prostate Cancer Clinical Trials, AXI Gets Oil from Algae, PATH Prepares to Launch “Ultra Rice,” & More Deals News Gregory T. Huang 08/18/08 Seattle
Accelerator Bankrolls New Company, Mirina, To Develop MicroRNA-Blocking Drugs Luke Timmerman 08/15/08 Seattle
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen Gregory T. Huang 05/22/08 Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million Erik Mellgren 04/17/08 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.